Trial site
Mater Private Hospital
- 13running trials
- 3closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer6 trials
- Lung cancer5 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Heart failure1 trial
- Kidney cancer1 trial
- Multiple myeloma1 trial
- Phase
- Phase 314 trials
- Phase 22 trials
- Status
- Active, not recruiting6 trials
- Recruiting6 trials
- Completed3 trials
- Not yet recruiting1 trial
- Lead sponsor
- University of Sydney3 trials
- UNICANCER2 trials
- AbbVie1 trial
- AstraZeneca1 trial
- Bristol-Myers Squibb1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
Active, not recruiting
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Active, not recruiting
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Prostate cancer3 recruiting
- Colorectal cancer1 recruiting
Closed trials
Active, not recruiting
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026